Loading...
•
Sep 30, 2024
ClearPoint Neuro Q3 2024 Earnings Report
Achieved record revenue and growth of 41% and operational cash burn was reduced to $1.2 million.
Key Takeaways
ClearPoint Neuro reported a record revenue quarter with $8.1 million, a 41% year-over-year increase. The company's growth was fueled by new product introductions, adoption of the PRISM laser therapy system, and expansion of pre-clinical capabilities. Operational cash burn was reduced, and the company reaffirmed its full year 2024 revenue outlook of between $30.0 and $33.0 million.
Reported quarterly revenue of $8.1 million, a 41% year-over-year increase.
Navigation and device revenue was $2.9 million, a 49% year-over-year increase.
Overall product revenue, including biologics and drug delivery, grew 127% to $5.5 million.
Quarterly operational cash burn reduced to $1.2 million, a 33% year-over-year decrease.
Revenue by Segment
Forward Guidance
The Company reaffirms its full year 2024 revenue outlook of between $30.0 and $33.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...